TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 308 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q2 2020. The put-call ratio across all filers is 1.16 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $138,046,000 | -6.5% | 7,584,930 | -8.3% | 26.79% | -6.6% |
| Q3 2020 | $147,612,000 | -10.1% | 8,274,227 | -9.6% | 28.67% | -20.4% |
| Q2 2020 | $164,172,000 | +16.5% | 9,156,315 | -1.4% | 36.01% | +6.5% |
| Q1 2020 | $140,909,000 | -20.3% | 9,282,543 | +3.6% | 33.82% | +0.2% |
| Q4 2019 | $176,757,000 | +14.3% | 8,958,784 | -0.4% | 33.75% | +1.0% |
| Q3 2019 | $154,650,000 | +10.2% | 8,991,290 | +13.4% | 33.43% | +1.5% |
| Q2 2019 | $140,381,000 | -25.7% | 7,931,116 | -14.4% | 32.92% | -15.9% |
| Q1 2019 | $188,841,000 | – | 9,270,535 | – | 39.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Adelphi Capital LLP | 8,958,784 | $176,757,000 | 33.75% |
| Ovata Capital Management Ltd | 879,800 | $17,557,092,000 | 13.04% |
| Paulson & Co. | 13,244,711 | $261,318,000 | 5.64% |
| Glenview Capital Management | 30,582,721 | $603,397,000 | 5.28% |
| MIC CAPITAL PARTNERS (PUBLIC) (US) IM, LLC | 718,028 | $14,167,000 | 4.85% |
| Velanne Asset Management Ltd | 302,694 | $5,972,000 | 3.52% |
| Blackcrane Capital, LLC | 172,708 | $3,408,000 | 2.72% |
| Melqart Asset Management (UK) Ltd | 1,557,000 | $30,720,000 | 2.57% |
| GMT CAPITAL CORP | 3,345,976 | $66,016,000 | 2.55% |
| REDWOOD CAPITAL MANAGEMENT, LLC | 827,955 | $16,336,000 | 2.24% |